Combination and Novel Pharmacologic Agents for OAB

Area of Science:

• Urology
• Pharmacology
• Nephrology

Background:

• Overactive bladder (OAB) is a complex condition involving neural, muscular, and urothelial dysfunction.
• Current treatments often have high discontinuation rates and limited efficacy.

Purpose of the Study:

• To review recent literature on combination and novel pharmacologic therapies for overactive bladder (OAB).

Main Methods:

• Literature review of recent studies on OAB treatments.
• Analysis of combination therapies and novel pharmacologic agents.

Main Results:

• Combination therapies (e.g., anticholinergics with β-3 agonists or neuromodulation) are more effective than monotherapy.
• Novel agents like selective anticholinergics, new β-3 agonists, and gabapentin show promise.

Conclusions:

• Diversifying therapeutic targets through combination therapy enhances OAB treatment efficacy.
• Novel treatments targeting additional pathways represent a promising future direction for OAB management.